Iproteos Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Iproteos General Information

Description

Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The company's therapy specializes in the research and development of third-generation drugs, such as protein-protein interactions (PPIs), enabling medical professionals to treat schizophrenia, epilepsy, pediatric cancer and other neurological disorders.

Contact Information

Website
www.iproteos.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain
+34 934
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Accure Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain
+34 934

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iproteos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 28-May-2020 Completed Generating Revenue
8. Early Stage VC (Series A) 15-Jul-2018 Completed Generating Revenue
7. Grant 29-May-2017 Completed Generating Revenue
6. Seed Round 25-Oct-2016 Completed Pre-Clinical Trials
5. Equity Crowdfunding 26-Sep-2016 Completed Pre-Clinical Trials
4. Seed Round 03-Jun-2015 Completed Startup
3. Equity Crowdfunding 01-Nov-2014 Completed Startup
2. Grant 01-Jan-2014 $686K $144K Completed Startup
1. Capitalization 01-Jan-2012 $144K $144K Completed Startup
To view Iproteos’s complete valuation and funding history, request access »

Iproteos Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Iproteos’s complete cap table history, request access »

Iproteos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The
Drug Discovery
Barcelona, Spain

Charlestown, MA
 

Barcelona, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iproteos Competitors (28)

One of Iproteos’s 28 competitors is Solid Biosciences, a Formerly VC-backed company based in Charlestown, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Solid Biosciences Formerly VC-backed Charlestown, MA
Minoryx Venture Capital-Backed Barcelona, Spain
Taysha Gene Therapies Formerly VC-backed Dallas, TX
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Tenaya Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 28 competitors. Get the full list »

Iproteos Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
ASCIL Biopharm Corporation Minority
Caixa Capital Risc Corporate Venture Capital Minority
Criteria Bio Ventures Venture Capital Minority
Horizon 2020 Government
Kinled Holding Family Office Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Iproteos FAQs

  • When was Iproteos founded?

    Iproteos was founded in 2011.

  • Where is Iproteos headquartered?

    Iproteos is headquartered in Barcelona, Spain.

  • What industry is Iproteos in?

    Iproteos’s primary industry is Drug Discovery.

  • Is Iproteos a private or public company?

    Iproteos is a Private company.

  • What is Iproteos’s current revenue?

    The current revenue for Iproteos is .

  • How much funding has Iproteos raised over time?

    Iproteos has raised $5.19M.

  • Who are Iproteos’s investors?

    ASCIL Biopharm, Caixa Capital Risc, Criteria Bio Ventures, Horizon 2020, and Kinled Holding are 5 of 6 investors who have invested in Iproteos.

  • Who are Iproteos’s competitors?

    Solid Biosciences, Minoryx, Taysha Gene Therapies, Sarepta Therapeutics, and Tenaya Therapeutics are some of the 28 competitors of Iproteos.

  • When was Iproteos acquired?

    Iproteos was acquired on 28-May-2020.

  • Who acquired Iproteos?

    Iproteos was acquired by Accure Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process